犬用疫苗疫苗类型、应用、给药途径、最终用户和地区划分

犬用疫苗市场规模预计在 2025 年达到 22.1 亿美元，预计到 2032 年将达到 35.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.8%。

已开发国家宠物饲养业的发展导致宠物犬疫苗接种范围扩大。美国动物医院协会等组织对宠物年度疫苗接种的严格规定进一步推动了犬用疫苗的需求。此外，宠物医疗保健支出的增加以及饲主对预防保健意识的不断增强，预计将在预测期内推动市场成长。然而，兽医护理和疫苗生产的高成本可能会在未来几年在一定程度上抑制市场成长。

市场动态

全球犬用疫苗市场是由全球宠物拥有量的成长所驱动的。宠物日益人性化以及宠物医疗保健支出的增加，大大促进了家庭宠物拥有。此外，要求每年为狗接种疫苗的严格规定正在创造对犬用疫苗的稳定需求。然而，疫苗生产和兽医服务的高成本给市场参与企业带来了重大挑战。此外，某些地区缺乏标准的兽医护理实践，抑制了市场成长。然而，针对多种疾病的新型疫苗的持续研发正在创造新的机会。此外，主要企业透过社群媒体行销宣传活动提高知名度也为市场提供了成长前景。

本次调查的主要特点

• 本报告对全球犬用疫苗市场进行了详细分析，并以 2024 年为基准年，提供了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
• 它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球犬用疫苗市场的主要企业概况。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
• 全球犬用疫苗市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 透过全球犬用疫苗市场分析中使用的各种策略矩阵，相关人员将更容易做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020-2032 年全球犬用疫苗市场（依疫苗类型）

• 介绍
• 减毒活病毒疫苗
• 灭活疫苗
• 次单位疫苗
• 类毒素疫苗
• DNA疫苗
• 重组疫苗
• 其他的

5. 全球犬用疫苗市场（按应用划分），2020-2032 年

• 介绍
• 犬小病毒
• 犬瘟热
• 犬腺病毒
• 钩端螺旋体病
• 博德氏菌
• 狂犬病

6. 全球犬用疫苗市场（依给药途径），2020-2032 年

• 介绍
• 注射疫苗
• 口服疫苗
• 鼻内疫苗

7. 全球犬用疫苗市场（以最终用户划分），2020-2032 年

• 介绍
• 兽医诊所
• 兽医诊所
• 居家照护
• 其他的

8. 全球犬用疫苗市场（按地区划分），2020-2032 年

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第九章 竞争态势

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Bayer Animal Health
• Ceva Sante Animale
• Virbac
• Vetoquinol
• Heska Corporation
• Neogen Corporation
• IDEXX Laboratories
• Merial（Sanofi）
• Phibro Animal Health
• Aratana Therapeutics
• Kemin Industries

第 10 章分析师建议

• 机会
• 一致的机会地图

第 11 章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Dogs Vaccines Market is estimated to be valued at USD 2.21 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Growing pet adoption across developed nations has increased the scope for vaccination of pet dogs. Stringent regulations regarding annual vaccination of pets by organizations such as American Animal Hospital Association has further augmented the demand for dog vaccines. Also, increasing pet healthcare expenditure and rising awareness among pet owners about preventive care are the key factors expected to drive the market growth during the forecast period. However, high costs associated with veterinary care and vaccine production may restrain the market growth to some extent over the next few years.

Market Dynamics

The global dog vaccines market is driven by increasing pet adoption worldwide. Growing humanization of pets and rising expenditure on pet healthcare have significantly boosted the adoption of pets across households. Moreover, stringent regulations mandating annual vaccination of dogs have created steady demand for dog vaccines. However, high costs associated with vaccine production and veterinary services pose a major challenge for market players. Furthermore, lack of standard practices for veterinary care in certain regions restrain the market growth. On the flip side, ongoing research & development activities for novel vaccines catering to multiple diseases present new opportunities. Rising awareness through social media marketing campaigns by key players also offers growth prospects for the market.

Key Features of the Study

• This report provides in-depth analysis of the global dog vaccines market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global dog vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Bayer Animal Health, Ceva Sante Animale, Virbac, Vetoquinol, Heska Corporation, Neogen Corporation, IDEXX Laboratories, Merial (Sanofi), Phibro Animal Health, Aratana Therapeutics, and Kemin Industries
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global dog vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dog vaccines market

Market Segmentation

• Type of Vaccine Insights (Revenue, USD Bn, 2020 - 2032)
  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Canine Parvovirus
  • Canine Distemper
  • Canine Adenovirus
  • Leptospirosis
  • Bordetella
  • Rabies
• Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Injectable Vaccines
  • Oral Vaccines
  • Intranasal Vaccines
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Veterinary Clinics
  • Animal Hospitals
  • Home Care Settings
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Bayer Animal Health
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol
  • Heska Corporation
  • Neogen Corporation
  • IDEXX Laboratories
  • Merial (Sanofi)
  • Phibro Animal Health
  • Aratana Therapeutics
  • Kemin Industries

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Dogs Vaccines Market, By Type of Vaccine
  • Global Dogs Vaccines Market, By Application
  • Global Dogs Vaccines Market, By Route of Administration
  • Global Dogs Vaccines Market, By End User
  • Global Dogs Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Dogs Vaccines Market, By Type of Vaccine, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Attenuated Live Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Inactivated Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Subunit Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Toxoid Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• DNA Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Recombinant Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

5. Global Dogs Vaccines Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Canine Parvovirus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Canine Distemper
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Canine Adenovirus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Leptospirosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Bordetella
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Rabies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

6. Global Dogs Vaccines Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Injectable Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Oral Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intranasal Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

7. Global Dogs Vaccines Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Veterinary Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Animal Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2032, (USD Bn)

8. Global Dogs Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021- 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Vaccine, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Vaccine, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021- 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Zoetis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elanco Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ceva Sante Animale
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Virbac
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vetoquinol
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Heska Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Neogen Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IDEXX Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merial (Sanofi)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Phibro Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aratana Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kemin Industries
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us